🇺🇲🇺🇲#Massachusetts 

At 5pm, @moderna_tx. dropped the news that its COVID-19 vaccine candidate produced "robust" immune response in all it's 45 patients in its, And I stress, early human trials. 
Shares of Moderna climbed 21%.

#whatmovesdaux #Moderna #DowJones #NASDAQ #SP500 https://t.co/Cg3Bbt8G4y